Why You Should Invest In Psychedelic Stocks
Psychedelic stocks are on the rise, and the timing couldn’t be better. While some of these companies are already publicly traded, many of them will have their initial public offerings (IPOs) in 2022, creating new opportunities for those who want to capitalize on the growing popularity of psilocybin mushrooms and LSD as health supplements and recreational drugs alike. What Are Psychedelics? The term psychedelic was coined by British psychiatrist Humphry Osmond and stems from two Greek words that mean mind-manifesting. Psychedelics can produce profound changes in perception, thoughts, feelings, and a sense of expanded spiritual awareness. Common psychedelics include LSD (lysergic acid diethylamide), DMT (dimethyltryptamine), and psilocybin—but there are more than 200 others. As evidenced by clinical trials with psilocybin, these drugs have medicinal uses; in fact, research suggests they may also help with depression and addiction. Scientists think serotonin and other neurotr...